We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » No Financial Incentive to Complete Confirmatory Trials for Accelerated Approvals, Study Finds
No Financial Incentive to Complete Confirmatory Trials for Accelerated Approvals, Study Finds
A new study of cancer drugs awarded FDA accelerated approval debunks the theory that drugmakers benefit financially from postmarket confirmatory trials that support the approval.